- Home
- PPCB vs PIII Comparison
PPCB vs PIII Comparison
Compare PPCB & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PPCB | PIII |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Nursing Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.4M | 17.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PPCB | PIII |
|---|---|---|
| Price | $0.72 | $4.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.25 |
| AVG Volume (30 Days) | ★ 257.4K | 10.3K |
| Earning Date | 11-17-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,444,952,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.72 | $4.48 |
| 52 Week High | $145.46 | $14.50 |
Technical Indicators
Market Signals| Indicator | PPCB | PIII |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 22.92 |
| Support Level | N/A | $5.01 |
| Resistance Level | N/A | $5.20 |
| Average True Range (ATR) | 0.00 | 0.22 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 0.74 |
Price Performance
Historical ComparisonAbout PPCB Propanc Biopharma Inc.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.